Cargando...
Rituximab for Refractory Rheumatoid Arthritis: A 24-Week Open-Label Prospective Study
OBJECTIVES: To study the efficacy of rituximab in active rheumatoid arthritis (RA) patients refractory to disease modifying anti-rheumatic drugs (DMARDs) including the tumor necrosis factor (TNF)-α antagonists. METHODS: Adult patients with active RA despite adequate therapies with conventional DMARD...
Gardado en:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Bentham Science Publishers Ltd.
2007
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2581826/ https://ncbi.nlm.nih.gov/pubmed/19088893 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874312900701010001 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|